The antiparasite activity of bioactive isoflavans from Tabebuia chrysantha timber by-products
ABSTRACT: Parasitic diseases, including malaria, leishmaniasis, and Chagas disease, represent one of the most significant morbidity and mortality burdens worldwide, and many of them affect the most impoverished populations of the world but very few therapeutic options are available. Timber by-produc...
- Autores:
-
Correa, Edwin
Robledo Restrepo, Sara María
Echeverri López, Luis Fernando
Quiñones Fletcher, Winston
Torres, Fernando
- Tipo de recurso:
- http://purl.org/coar/resource_type/c_6670
- Fecha de publicación:
- 2022
- Institución:
- Universidad de Antioquia
- Repositorio:
- Repositorio UdeA
- Idioma:
- eng
- OAI Identifier:
- oai:bibliotecadigital.udea.edu.co:10495/34758
- Acceso en línea:
- https://hdl.handle.net/10495/34758
- Palabra clave:
- Malaria
Antiparasitarios
Antiparasitic Agents
Enfermedades Parasitarias
Parasitic Diseases
Leishmaniasis
Enfermedad de Chagas
Chagas Disease
Extractos Vegetales
Plant Extracts
Leishmania braziliensis
Trypanosoma cruzi
Plasmodium falciparum
Metabolitos secundarios
Secondary metabolites
Tabebuia chrysantha
Guayacán Amarillo
http://aims.fao.org/aos/agrovoc/c_34335
- Rights
- openAccess
- License
- https://creativecommons.org/licenses/by-nc-sa/4.0/
| Summary: | ABSTRACT: Parasitic diseases, including malaria, leishmaniasis, and Chagas disease, represent one of the most significant morbidity and mortality burdens worldwide, and many of them affect the most impoverished populations of the world but very few therapeutic options are available. Timber by-products are an interesting and emerging source of secondary metabolites. Tabebuia chrysantha (Jacq.) G. Nicholson 1887, is a tree of the Family Bignoniaceae, commonly known by the name of “guayacan Amarillo” (yellow guayacan). It is native to the dry forests of the American intertropical zone. Through bio-guided in vitro assays, high activities in the ethanolic extract (SQB-11) and metabolites from T. chrysantha sawdust were detected against Leishmania braziliensis, Trypanosoma cruzi and Plasmodium falciparum. |
|---|
